Trivedi MH - Search Results

1

Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.

Connor KM, Ceesay P, Hutzelmann J, Snavely D, Krystal AD, Trivedi MH, Thase M, Lines C, Herring WJ, Michelson D. Connor KM, et al. Among authors: trivedi mh. Int J Neuropsychopharmacol. 2017 Aug 1;20(8):613-618. doi: 10.1093/ijnp/pyx033. Int J Neuropsychopharmacol. 2017. PMID: 28582570 Free PMC article. Clinical Trial.

2

MAOIs in the contemporary treatment of depression.

Thase ME, Trivedi MH, Rush AJ. Thase ME, et al. Among authors: trivedi mh. Neuropsychopharmacology. 1995 May;12(3):185-219. doi: 10.1016/0893-133X(94)00058-8. Neuropsychopharmacology. 1995. PMID: 7612154

3

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

Trivedi MH, Rush H. Trivedi MH, et al. Neuropsychopharmacology. 1994 Aug;11(1):33-43. doi: 10.1038/npp.1994.63. Neuropsychopharmacology. 1994. PMID: 7945742

4

The effects of nefazodone on sleep architecture in depression.

Armitage R, Rush AJ, Trivedi M, Cain J, Roffwarg HP. Armitage R, et al. Neuropsychopharmacology. 1994 Apr;10(2):123-7. doi: 10.1038/npp.1994.14. Neuropsychopharmacology. 1994. PMID: 8024673

5

Consensus guidelines in the treatment of major depressive disorder.

Rush AJ, Crismon ML, Toprac MG, Trivedi MH, Rago WV, Shon S, Altshuler KZ. Rush AJ, et al. Among authors: trivedi mh. J Clin Psychiatry. 1998;59 Suppl 20:73-84. J Clin Psychiatry. 1998. PMID: 9881540

6

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.

Lotufo-Neto F, Trivedi M, Thase ME. Lotufo-Neto F, et al. Neuropsychopharmacology. 1999 Mar;20(3):226-47. doi: 10.1016/S0893-133X(98)00075-X. Neuropsychopharmacology. 1999. PMID: 10063483

7

The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.

Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, DeBattista C, Nelson JC, Nierenberg AA, Sackeim HA, Thase ME. Crismon ML, et al. J Clin Psychiatry. 1999 Mar;60(3):142-56. J Clin Psychiatry. 1999. PMID: 10192589 Review.

8

Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline.

Rush AJ, Trivedi MH, Carmody TJ, Donahue RM, Houser TL, Bolden-Watson C, Batey SR, Ascher JA, Metz A. Rush AJ, et al. Among authors: trivedi mh. Neuropsychopharmacology. 2001 Jul;25(1):131-8. doi: 10.1016/S0893-133X(00)00249-9. Neuropsychopharmacology. 2001. PMID: 11377926 Clinical Trial.

9

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.

Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB. Hirschfeld RM, et al. Among authors: trivedi mh. Biol Psychiatry. 2002 Jan 15;51(2):123-33. doi: 10.1016/s0006-3223(01)01291-4. Biol Psychiatry. 2002. PMID: 11822991 Clinical Trial.

10

Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB. Ninan PT, et al. Among authors: trivedi mh. J Clin Psychiatry. 2002 May;63(5):434-41. doi: 10.4088/jcp.v63n0510. J Clin Psychiatry. 2002. PMID: 12025827 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

639 results

Search Page

Filters